Literature DB >> 11246146

Involvement of protein kinase Cgamma isoform in morphine-induced reinforcing effects.

M Narita1, T Aoki, S Ozaki, Y Yajima, T Suzuki.   

Abstract

The present study was designed to investigate the role of protein kinase C (PKC) isoform in the morphine-induced reinforcing effect in mice. An intracerebroventricular injection of calphostin C, a specific PKC inhibitor, produced a dose-dependent reduction in the morphine-induced place preference. The protein level of PKCgamma was significantly up-regulated in membrane preparations of the limbic forebrain obtained from the morphine-conditioned mice compared to that from the saline-conditioned mice. However, the protein levels of PKCalpha, betaI, betaII and epsilon were not affected in the same preparation. By contrast, there were no changes in the protein level of all five PKC isoforms in the lower midbrain. Furthermore, we investigated the rewarding properties of morphine in mice lacking PKCgamma gene. A significant place preference was observed following treatment with morphine in wild-type mice, whereas such an effect of morphine was not found in PKCgamma knockout mice. These findings suggest that activated PKCgamma in the limbic forebrain following the treatment with morphine may be critical for the development and/or maintenance of reinforcing effects induced by morphine in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246146     DOI: 10.1016/s0306-4522(00)00572-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

Review 1.  Protein kinase C isozymes and addiction.

Authors:  M Foster Olive; Robert O Messing
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

2.  Effect of glycine site/NMDA receptor antagonist MRZ2/576 on the conditioned place preference and locomotor activity induced by morphine in mice.

Authors:  Yong-ping Zhu; Zai-hao Long; Ming-lan Zheng; Ralf Binsack
Journal:  J Zhejiang Univ Sci B       Date:  2006-12       Impact factor: 3.066

Review 3.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 4.  Protein kinase C isozymes as regulators of sensitivity to and self-administration of drugs of abuse-studies with genetically modified mice.

Authors:  Michael Foster Olive; Philip M Newton
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

5.  Increased response to morphine in mice lacking protein kinase C epsilon.

Authors:  P M Newton; J A Kim; A J McGeehan; J P Paredes; K Chu; M J Wallace; A J Roberts; C W Hodge; R O Messing
Journal:  Genes Brain Behav       Date:  2006-08-07       Impact factor: 3.449

Review 6.  A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?

Authors:  Erika Abrial; Guillaume Lucas; Hélène Scarna; Nasser Haddjeri; Laura Lambás-Señas
Journal:  Mol Neurobiol       Date:  2011-10-05       Impact factor: 5.590

7.  Cocaine facilitates PKC maturation by upregulating its phosphorylation at the activation loop in rat striatal neurons in vivo.

Authors:  Bing Xue; Ming-Lei Guo; Dao-Zhong Jin; Li-Min Mao; John Q Wang
Journal:  Brain Res       Date:  2011-11-13       Impact factor: 3.252

8.  Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine.

Authors:  Jenica D Tapocik; Noah Letwin; Cheryl L Mayo; Bryan Frank; Troung Luu; Ovokeraye Achinike; Carrie House; Russell Williams; Greg I Elmer; Norman H Lee
Journal:  J Neurosci       Date:  2009-04-22       Impact factor: 6.167

Review 9.  The role of signaling molecules in reward-related incentive learning.

Authors:  Richard J Beninger; Todor Gerdjikov
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

10.  Striatal signal transduction and drug addiction.

Authors:  Scott D Philibin; Adan Hernandez; David W Self; James A Bibb
Journal:  Front Neuroanat       Date:  2011-09-20       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.